Publications (73) Concepción Blanco Carrera publications

filter_list

2025

  1. ASO Visual Abstract: Outcomes for Patients with Obesity Undergoing Adrenalectomy for Pheochromocytoma-An International Multicenter Analysis

    Annals of surgical oncology, Vol. 32, Núm. 4, pp. 2376-2378

  2. Does Adjuvant Mitotane Impact Cure Rates in Adrenocortical Carcinoma? Insights From the ICARO-GETTHI/SEEN Registry

    Journal of Clinical Endocrinology and Metabolism, Vol. 110, Núm. 11, pp. 3155-3167

  3. Outcomes for Patients with Obesity Undergoing Adrenalectomy for Pheochromocytoma: An International Multicenter Analysis

    Annals of Surgical Oncology, Vol. 32, Núm. 3, pp. 1709-1720

  4. Postoperative Outcomes in Normotensive and Hypertensive Pheochromocytomas: An International Study

    Journal of Clinical Endocrinology and Metabolism, Vol. 110, Núm. 11, pp. e3719-e3729

  5. Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas

    Endocrine Connections, Vol. 14, Núm. 7

  6. Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly

    Pituitary, Vol. 28, Núm. 6

  7. Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study

    European Urology Focus, Vol. 11, Núm. 1, pp. 118-125

2024

  1. Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases

    Journal of Clinical Endocrinology and Metabolism, Vol. 109, Núm. 12, pp. e2178-e2187

  2. ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-related cancer

  3. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

  4. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

    Pituitary, Vol. 27, Núm. 5, pp. 497-506

  5. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433

  6. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-Related Cancer, Vol. 31, Núm. 7

  7. Personalized Medicine in Acromegaly: The ACROFAST Study

    The Journal of clinical endocrinology and metabolism, Vol. 110, Núm. 1, pp. 30-40

  8. Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas

    Journal of Hypertension, Vol. 42, Núm. 2, pp. 252-259

2023

  1. An Integrated CT and MRI Imaging Model to Differentiate between Adrenal Adenomas and Pheochromocytomas

    Cancers, Vol. 15, Núm. 14

  2. Development of hypoglycemia in a patient with type 1 diabetes mellitus: A little-known adverse effect of linezolid

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 10, pp. 654-656

  3. Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY

    Journal of Endocrinological Investigation, Vol. 46, Núm. 4, pp. 805-814

  4. Genetic Study in Pheochromocytoma: Is It Possible to Stratify the Risk of Hereditary Pheochromocytoma?

    Neuroendocrinology, Vol. 113, Núm. 6, pp. 657-666

  5. Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas

    Frontiers in Endocrinology, Vol. 14